{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:34:48Z","timestamp":1762972488382,"version":"3.45.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,12]]},"DOI":"10.7759\/cureus.96690","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:29:45Z","timestamp":1762972185000},"source":"Crossref","is-referenced-by-count":0,"title":["A Clinical Case of Anti-synthetase Syndrome: Polysymptomatic and Underdiagnosed"],"prefix":"10.7759","author":[{"given":"Nuno","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"San Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Amorim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2018.17167","article-title":"Novel case of anti-synthetase syndrome","volume":"5","author":"Kapoor A","year":"2018","unstructured":"Kapoor A, Vaidyan P, Jalil B, Upaluri C. Novel case of anti-synthetase syndrome. Eur J Rheumatol. 2018, 5:275-7. 10.5152\/eurjrheum.2018.17167","journal-title":"Eur J Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.022","article-title":"Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review","volume":"13","author":"Mahler M","year":"2014","unstructured":"Mahler M, Miller FW, Fritzler MJ. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmun Rev. 2014, 13:367-71. 10.1016\/j.autrev.2014.01.022","journal-title":"Autoimmun Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060442","article-title":"Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome","volume":"8","author":"Hamaguchi Y","year":"2013","unstructured":"Hamaguchi Y, Fujimoto M, Matsushita T, et al.. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS One. 2013, 8:e60442. 10.1371\/journal.pone.0060442","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201800","article-title":"Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients","volume":"73","author":"Aggarwal R","year":"2014","unstructured":"Aggarwal R, Cassidy E, Fertig N, Koontz DC, Lucas M, Ascherman DP, Oddis CV. Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis. 2014, 73:227-32. 10.1136\/annrheumdis-2012-201800","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.01.006","article-title":"Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome","volume":"11","author":"Marie I","year":"2012","unstructured":"Marie I, Josse S, Decaux O, et al.. Comparison of long-term outcome between anti-Jo1- and anti-PL7\/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev. 2012, 11:739-45. 10.1016\/j.autrev.2012.01.006","journal-title":"Autoimmun Rev"},{"key":"ref6","article-title":"New insights into antisynthetase syndrome","volume":"11","author":"Cojocaru M","year":"2016","unstructured":"Cojocaru M, Cojocaru IM, Chicos B. New insights into antisynthetase syndrome. Maedica (Bucur). 2016, 11:130-5.","journal-title":"Maedica (Bucur)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/8xj0b9","article-title":"Defining anti-synthetase syndrome: a systematic literature review","volume":"40","author":"Zanframundo G","year":"2022","unstructured":"Zanframundo G, Faghihi-Kashani S, Scir\u00e8 CA, et al.. Defining anti-synthetase syndrome: a systematic literature review. Clin Exp Rheumatol. 2022, 40:309-19. 10.55563\/clinexprheumatol\/8xj0b9","journal-title":"Clin Exp Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-021-01399-5","article-title":"Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China","volume":"21","author":"Zhan X","year":"2021","unstructured":"Zhan X, Yan W, Wang Y, Li Q, Shi X, Gao Y, Ye Q. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China. BMC Pulm Med. 2021, 21:57. 10.1186\/s12890-021-01399-5","journal-title":"BMC Pulm Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3233\/JND-180308","article-title":"Current classification and management of inflammatory myopathies","volume":"5","author":"Schmidt J","year":"2018","unstructured":"Schmidt J. Current classification and management of inflammatory myopathies. J Neuromuscul Dis. 2018, 5:109-29. 10.3233\/JND-180308","journal-title":"J Neuromuscul Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-020-01388-0","article-title":"Anti-synthetase syndrome: a rare and challenging diagnosis for bilateral ground-glass opacities-a case report with literature review","volume":"21","author":"Alfraji N","year":"2021","unstructured":"Alfraji N, Mazahir U, Chaudhri M, Miskoff J. Anti-synthetase syndrome: a rare and challenging diagnosis for bilateral ground-glass opacities-a case report with literature review. BMC Pulm Med. 2021, 21:11. 10.1186\/s12890-020-01388-0","journal-title":"BMC Pulm Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-20-3328","article-title":"A narrative review of interstitial lung disease in anti-synthetase syndrome: a clinical approach","volume":"13","author":"Sawal N","year":"2021","unstructured":"Sawal N, Mukhopadhyay S, Rayancha S, Moore A, Garcha P, Kumar A, Kaul V. A narrative review of interstitial lung disease in anti-synthetase syndrome: a clinical approach. J Thorac Dis. 2021, 13:5556-71. 10.21037\/jtd-20-3328","journal-title":"J Thorac Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12936","article-title":"Anti-synthetase syndrome-related interstitial lung disease with anti-PL-12 antibodies","volume":"13","author":"Elferjani B","year":"2021","unstructured":"Elferjani B, Liaqat A, Zaman M, Sexton M. Anti-synthetase syndrome-related interstitial lung disease with anti-PL-12 antibodies. Cureus. 2021, 13:e12936. 10.7759\/cureus.12936","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg IE","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, et al.. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017, 76:1955-64. 10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/CPM.0000000000000171","article-title":"The diagnosis and treatment of antisynthetase syndrome","volume":"23","author":"Witt LJ","year":"2016","unstructured":"Witt LJ, Curran JJ, Strek ME. The diagnosis and treatment of antisynthetase syndrome. Clin Pulm Med. 2016, 23:218-26. 10.1097\/CPM.0000000000000171","journal-title":"Clin Pulm Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5414\/NP301077","article-title":"Idiopathic inflammatory myopathies overlapping with systemic diseases","volume":"37","author":"Lepreux S","year":"2018","unstructured":"Lepreux S, Hainfellner JA, Vital A. Idiopathic inflammatory myopathies overlapping with systemic diseases. Clin Neuropathol. 2018, 37:6-15. 10.5414\/NP301077","journal-title":"Clin Neuropathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.36185\/2532-1900-032","article-title":"Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications","volume":"39","author":"Dalakas MC","year":"2020","unstructured":"Dalakas MC. Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications. Acta Myol. 2020, 39:289-301. 10.36185\/2532-1900-032","journal-title":"Acta Myol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/404267-a-clinical-case-of-anti-synthetase-syndrome-polysymptomatic-and-underdiagnosed","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:29:46Z","timestamp":1762972186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/404267-a-clinical-case-of-anti-synthetase-syndrome-polysymptomatic-and-underdiagnosed"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.96690","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,12]]}}}